niacinamide has been researched along with cholecalciferol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Raska, I; Toropov, AA; Toropova, AP | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Isler, O | 1 |
Bolevich, SB; Omarov, IA; Savateeva-Liubimova, TN; Silina, EV; Sivak, KV | 1 |
Garg, R; Verma, H | 1 |
1 trial(s) available for niacinamide and cholecalciferol
Article | Year |
---|---|
[Oxidative stress and combined antioxidant energy correction in the treatment of periodontitis].
Topics: Adult; Aged; Animals; Antioxidants; Calcium; Cholecalciferol; Chronic Disease; Drug Combinations; Drug Therapy, Combination; Energy Metabolism; Female; Flavin Mononucleotide; Free Radicals; Humans; Inosine Diphosphate; Male; Middle Aged; Niacinamide; Oxidative Stress; Periodontitis; Rats; Rats, Wistar; Succinates | 2011 |
4 other study(ies) available for niacinamide and cholecalciferol
Article | Year |
---|---|
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
Topics: Models, Molecular; Models, Statistical; Molecular Structure; Octanols; Quantitative Structure-Activity Relationship; Vitamins; Water | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developments in the field of vitamins.
Topics: Acetone; Alcohols; Ascorbic Acid; Biotin; Cholecalciferol; Folic Acid; Niacinamide; Pantothenic Acid; Pyridoxine; Riboflavin; Stereoisomerism; Thiamine; Ubiquinone; Vitamin A; Vitamin B 12; Vitamin E; Vitamin K 1; Vitamins | 1970 |
Evaluation of synergistic combination comprising magnesium orotate, menaquinone-7, and cholecalciferol for management of type 2 diabetes and dyslipidemia.
Topics: Animals; Cholecalciferol; Diabetes Mellitus, Experimental; Disease Models, Animal; Dyslipidemias; Hypoglycemic Agents; Male; Niacinamide; Orotic Acid; Rats; Rats, Wistar; Streptozocin; Vitamin K 2 | 2020 |